Figure 1.

BMD of the posterior-anterior (PA) spine, femoral neck, one third radius, and total body determined by DXA in women randomized to alendronate alone (n = 29; red triangles), teriparatide alone (n = 20; blue squares), or both (n = 20; green circles). Teriparatide was begun at month 6. Data are plotted as the mean percent change (±sem). In women treated with teriparatide alone or teriparatide plus alendronate, data are presented starting at month 6 when teriparatide was begun. Error bars that are not seen are contained within the symbols.